Tobacco cessation pharmacotherapy — Nicotrol NS and Nicotrol Inhaler (Kentucky fully insured)
Policy governing prior authorization and coverage criteria for Nicotrol Nasal Spray and Nicotrol Inhaler for tobacco cessation under UnitedHealthcare Kentucky fully insured plans, aligned with Health Care Reform requirements for zero cost-share quit attempts.
Removed varenicline from PA requirements.
Removed reference to Zyban due to product becoming obsolete.
Effective date set to 11/1/2025 and program identifiers updated for 2025.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.